- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02596789
Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device (RC-TMS)
Study of Cortical Excitability in Healthy Subjects With Transcranial Magnetic Stimulation (TMS) and a Neuronavigation Device
This study has two main goals :
- to investigate the impact of aging on cortical excitability (CE)
- to investigate the impact of "state dependency" on CE, using a cognitive task and an emotional one.
A Neuronavigation system of transcranial magnetic stimulation is used, and electromyographic response are recorded.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38000
- Department of Psychiatry & Neurology - University Hospital Grenoble
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male or female
- age 18-75
- signed informed consent
- normal physical examination
Exclusion Criteria:
- less 18 or more 75 years of age
- contra indication to TMS: epilepsia or seizures, metallic head devices, cardiac pacemaker, pregnancy, jet lag or severe insomnia the night before
- severe physical disease
- treatment with psychotropic drugs
- overt psychiatric disease
- alcohol consumption before the examination
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: state dependency TMS
TMS performed at rest and during a cognitive/emotional task
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Amplitudes of Motor evoked Potentials (µV) for ICI and ICF.
Time Frame: Participants will be followed for an expected average of one month
|
Motor Evoked Potential (MEP) from the first dorsal interosseous are register during the stimulations. Intracortical Inhibition (ICI) and Facilitation (ICF) are a paired-pulse TMS measure of cortical excitability. A short Interval interstimuli (2ms) leads to a cortical inhibition, which reflects the GABAergic neurotransmission; whereas a longer interval interstimuli leads to a cortical facilitation, which reflects glutamatergic neurotransmission. |
Participants will be followed for an expected average of one month
|
Durations of Cortical Silent Period (ms)
Time Frame: Participants will be followed for an expected average of one month
|
Cortical Silent Period (CSP) is a single-pulse TMS measure of cortical inhibition, stimulations are applied while subjects are exerting a muscular contraction of the thum-index pinch and lead to a muscular cancellation.
Duration of this silence is measured.
|
Participants will be followed for an expected average of one month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thierry BOUGEROL, MD, PhD, University of Grenoble
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2012-A00316-37
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on TMS "Magpro®, Magventure Inc" device
-
Universidad Nacional Autonoma de MexicoUnknownMajor DepressionMexico
-
VA Office of Research and DevelopmentRecruiting
-
Wuerzburg University HospitalUniversity of WuerzburgCompleted
-
Stanford UniversityNational Institutes of Health (NIH); National Center for Complementary and...CompletedFibromyalgiaUnited States
-
National Institute on Drug Abuse (NIDA)Recruiting
-
Weill Medical College of Cornell UniversityThe New Venture Fund / Foundation for OCD Research; The Wellcome Leap FundRecruiting
-
Medical University of South CarolinaRecruitingStroke Sequelae | Motivation | Apathy | Stroke (CVA) or TIA | Stroke/Brain Attack | AbuliaUnited States
-
Auburn UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Recruiting
-
The Mind Research NetworkUniversity of New MexicoRecruitingTranscranial Magnetic Stimulation | Traumatic Brain Injury | Magnetic Resonance Imaging | Post-Concussion Syndrome | Neuropsychological TestsUnited States
-
University of MichiganNot yet recruitingParkinson DiseaseUnited States